[Remote] Manager, Statistical Programming at Gilead Sciences

United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must have a strong understanding of clinical trials design and reporting processes, with knowledge of clinical safety reporting requirements being a plus. Expertise in SAS programming, including the ability to write and use SAS macros for automation, is essential. Strong project management skills, including the ability to anticipate time, resources, and staffing needs for multiple concurrent projects, are required. Excellent verbal and written communication and interpersonal skills are also necessary.

Responsibilities

The Manager, Statistical Programming will serve as a project lead, overseeing outsourced safety analyses and acting as a fluent programmer for complex Clinical Safety Surveillance projects. Responsibilities include identifying analysis issues, assuring project quality, and negotiating project scope, milestones, and timelines with stakeholders. The role involves generating or overseeing the production of statistical outputs like tables and listings for safety analysis reports, harmonizing source data, and creating/validating analysis datasets and TLFs. The manager will also collaborate with Clinical Development staff, ensure programming consistency with departmental procedures, and potentially train or recommend training for others.

Skills

Statistical Programming

Clinical Safety Surveillance

SAS

Project Management

Vendor Management

Data Analysis

Regulatory Reporting

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free